The next 10 years for tuberculosis vaccines: do we have the right plans in place?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The next 10 years for tuberculosis vaccines: do we have the right plans in place?
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 12, Issue 4, Pages 443-451
Publisher
Informa UK Limited
Online
2013-04-06
DOI
10.1586/erv.13.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/orMycobacterium tuberculosis–infected Adults
- (2012) Thomas J. Scriba et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Controlled Human Blood Stage Malaria Infection: Current Status and Potential Applications
- (2012) Christopher J. A. Duncan et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
- (2012) Angela M. Minassian et al. JOURNAL OF INFECTIOUS DISEASES
- A sustainable agenda for tuberculosis control and research
- (2012) Mario Raviglione et al. LANCET
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
- (2012) Rolf Billeskov et al. PLoS One
- Meeting report: The international conference on human immunity to tuberculosis
- (2012) Joel D. Ernst et al. TUBERCULOSIS
- Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade
- (2012) Michael J. Brennan et al. TUBERCULOSIS
- A mouse model of tuberculosis reinfection
- (2012) Marcela Henao-Tamayo et al. TUBERCULOSIS
- Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
- (2012) Ansar A. Pathan et al. VACCINE
- Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
- (2011) Christiane Desel et al. JOURNAL OF INFECTIOUS DISEASES
- A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis
- (2011) Kari A Sweeney et al. NATURE MEDICINE
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Taking a New Shot At a TB Vaccine
- (2011) K. Kupferschmidt SCIENCE
- Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
- (2011) M. O. C. Ota et al. Science Translational Medicine
- Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis
- (2011) Ashwin S. Dharmadhikari et al. TUBERCULOSIS
- A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
- (2011) V.J. Gunther et al. VACCINE
- A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
- (2011) A. M. Minassian et al. BMJ Open
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Update on Research and Development Pipeline: Tuberculosis Vaccines
- (2010) Belinda Beresford et al. CLINICAL INFECTIOUS DISEASES
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
- (2010) Lukas Flatz et al. NATURE MEDICINE
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- Financing of global health: tracking development assistance for health from 1990 to 2007
- (2009) Nirmala Ravishankar et al. LANCET
- MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
- (2009) Frank A. W. Verreck et al. PLoS One
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- A comparison of IFNγ detection methods used in tuberculosis vaccine trials
- (2008) Natalie E.R. Beveridge et al. TUBERCULOSIS
- Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
- (2008) Willem A Hanekom et al. PLOS MEDICINE
- Eliminating human tuberculosis in the twenty-first century
- (2007) C. Dye et al. Journal of the Royal Society Interface
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now